Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis [0.03%]
内镜黏膜下剥离术与胃早癌(包括未分化型肿瘤)扩大适应证外科手术的长期结局：基于条目标准的分析
Sunpyo Lee,Kee Don Choi,Minkyu Han et al.
Sunpyo Lee et al.
Background: Endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) meeting the expanded indication is considered investigational. We aimed to compare long-term outcomes of ESD and surgery for EGC in the exp...
Development and validation of a risk assessment tool for gastric cancer in a general Japanese population [0.03%]
胃癌风险评估工具的开发和验证——基于日本普通人群的一项研究
Masahiro Iida,Fumie Ikeda,Jun Hata et al.
Masahiro Iida et al.
Background: There have been very few reports of risk score models for the development of gastric cancer. The aim of this study was to develop and validate a risk assessment tool for discerning future gastric cancer risk i...
Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study [0.03%]
eCura系统是否可用于选择接受不彻底内镜下黏膜下剥离术后的早期胃癌根治手术患者？一项对比研究
Waku Hatta,Takuji Gotoda,Tsuneo Oyama et al.
Waku Hatta et al.
Background: We have established a risk-scoring system, termed the "eCura system," for the risk stratification of lymph node metastasis in patients who have received noncurative endoscopic submucosal dissection (ESD) for e...
Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer? [0.03%]
根除幽门螺杆菌治疗对胃食管反流病症状的影响：一项随机对照试验
Kazumasa Fujitani,Yukinori Kurokawa,Atsushi Takeno et al.
Kazumasa Fujitani et al.
Background: Surgical resection with S-1 adjuvant chemotherapy (AC) is the standard of care for stage II-III gastric cancer (GC). However, it is unclear if time to initiation and duration of S-1 AC impact on survival. ...
The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging [0.03%]
美国癌症联合委员会（AJCC）第9版胃腺癌临床及新辅助治疗后病理分期方案
Haejin In,Ethan Ravetch,Marisa Langdon-Embry et al.
Haejin In et al.
Purpose: New stage grouping classifications for clinical (cStage) and post-neoadjuvant treatment (ypStage) stage for gastric adenocarcinoma have been proposed for the eighth edition of the AJCC manual. This article summar...
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06) [0.03%]
老年HER2阳性晚期胃癌患者曲妥珠单抗联合S-1单药治疗的多中心II期临床研究(JACCRO GC-06)
Yutaka Kimura,Masashi Fujii,Toshiki Masuishi et al.
Yutaka Kimura et al.
Background: S-1 plus cisplatin is a standard regimen for advanced gastric cancer (AGC) in Asia. The ToGA trial established a fluoropyrimidine plus cisplatin and trastuzumab as a standard treatment for human epidermal grow...
Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study [0.03%]
腹腔镜胃切除术后胰瘘发生率更高 一项全国多中心前瞻性队列研究的真实世界证据
Naoki Hiki,Michitaka Honda,Tsuyoshi Etoh et al.
Naoki Hiki et al.
Background: Laparoscopic distal gastrectomy (LDG) is becoming the standard procedure for gastric cancer. However, supporting evidence thus far has been derived primarily from randomized control trials conducted by centers...
How to adjust endoscopic findings to histopathological findings of the stomach: a "histopathology-oriented" correspondence method helps to understand endoscopic findings [0.03%]
内镜表现如何调整以适应胃的组织病理学改变：“以病理为导向”的对应方法有助于理解内镜表现
Yasuko Fujita,Mitsuo Kishimoto,Osamu Dohi et al.
Yasuko Fujita et al.
Background: Endoscopic findings have now become nearly as detailed as histopathological findings. Thus, one-to-one correspondence and precise feedback of histopathological findings is very desirable but may be very diffic...
An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma [0.03%]
低剂量CT灌注成像评估晚期胃腺癌新辅助化疗疗效的应用研究
Zongqiong Sun,Xiaofang Cheng,Yuxi Ge et al.
Zongqiong Sun et al.
Background: This study used low-dose computed tomography (CT) perfusion imaging technology to evaluate the efficacy of neoadjuvant chemotherapy in patients with advanced gastric adenocarcinoma and to determine whether any...
Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma [0.03%]
胃肠道腺癌胃切除、食管切除和联合食管胃切除术后的生命质量研究
Joonas H Kauppila,Cecilia Ringborg,Asif Johar et al.
Joonas H Kauppila et al.
Background: The postoperative health-related quality of life (HRQOL) outcomes in patients with gastroesophageal junction (GEJ) adenocarcinoma after gastrectomy and esophagectomy are unclear. The aim was to evaluate HRQOL ...